Literature DB >> 15073999

Inappropriate prescribing of compounded antiobesity formulas in Brazil.

S A Nappo1, E M de Oliveira, S Morosini.   

Abstract

Volunteers posing as patients underwent paid medical consultations at the offices of 107 Brazilian doctors (in two Brazilian cities) with the purpose of obtaining an antiobesity prescription. In 80.3% of 71 São Paulo visits, as well as in 47.2% of 36 Recife visits, compounded preparations were prescribed. Four to six active components predominated, but there were prescriptions listing as many as 17 components. All contained anorectic substances and benzodiazepines. Diuretics, thyroid agents, laxatives, medicinal plants, and a variety of other substances were often included. The prescribed doses were frequently above recommended limits, reaching amounts as much as five times the internationally defined standard doses. In some instances two anorectic substances were prescribed simultaneously. Most doctors failed to warn volunteers of the possible occurrence of adverse reactions to the prescribed substances. Furthermore, in the case of all volunteers involved, antiobesity prescriptions would be completely unnecessary, a fact that points to improper medical conduct on the part of doctors. It is concluded that the practice by some Brazilian medical doctors of prescribing manipulation formulas based on anorectic and benzodiazepine drugs is a greater hazard than a benefit to patients. Copyright 1998 John Wiley & Sons, Ltd.

Entities:  

Year:  1998        PMID: 15073999     DOI: 10.1002/(SICI)1099-1557(199805/06)7:3<207::AID-PDS335>3.0.CO;2-W

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  4 in total

1.  Imported fenproporex-based diet pills from Brazil: a report of two cases.

Authors:  Pieter A Cohen
Journal:  J Gen Intern Med       Date:  2009-03       Impact factor: 5.128

2.  Suspected adverse reaction to compounded preparations prescribed for weight loss: two cases of cerebral venous thrombosis.

Authors:  Beatrice Mainoli; Mariana Carvalho Dias; Patricia Canhão; Mário Miguel Rosa
Journal:  BMJ Case Rep       Date:  2020-03-31

Review 3.  Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.

Authors:  Rosa Camila Lucchetta; Bruno Salgado Riveros; Roberto Pontarolo; Rosana Bento Radominski; Michel Fleith Otuki; Fernando Fernandez-Llimos; Cassyano Januário Correr
Journal:  Clinics (Sao Paulo)       Date:  2017-05       Impact factor: 2.365

4.  The use of appetite suppressants among health sciences undergraduate students in Southern Brazil.

Authors:  Carlos Zubaran; Rubia Lazzaretti
Journal:  Einstein (Sao Paulo)       Date:  2013 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.